Skip to main navigation Skip to search Skip to main content

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia

Research output: Contribution to journalArticle (Academic Journal)peer-review

100 Citations (Scopus)

Abstract

Little is known about the contributors and physiological responses to white matter hypoperfusion in the human brain. We previously showed the ratio of myelin-associated glycoprotein to proteolipid protein 1 in post-mortem human brain tissue correlates with the degree of ante-mortem ischaemia. In age-matched post-mortem cohorts of Alzheimer's disease (n = 49), vascular dementia (n = 17) and control brains (n = 33) from the South West Dementia Brain Bank (Bristol), we have now examined the relationship between the ratio of myelin-associated glycoprotein to proteolipid protein 1 and several other proteins involved in regulating white matter vascularity and blood flow. Across the three cohorts, white matter perfusion, indicated by the ratio of myelin-associated glycoprotein to proteolipid protein 1, correlated positively with the concentration of the vasoconstrictor, endothelin 1 (P = 0.0005), and negatively with the concentration of the pro-angiogenic protein, vascular endothelial growth factor (P = 0.0015). The activity of angiotensin-converting enzyme, which catalyses production of the vasoconstrictor angiotensin II was not altered. In samples of frontal white matter from an independent (Oxford, UK) cohort of post-mortem brains (n = 74), we confirmed the significant correlations between the ratio of myelin-associated glycoprotein to proteolipid protein 1 and both endothelin 1 and vascular endothelial growth factor. We also assessed microvessel density in the Bristol (UK) samples, by measurement of factor VIII-related antigen, which we showed to correlate with immunohistochemical measurements of vessel density, and found factor VIII-related antigen levels to correlate with the level of vascular endothelial growth factor (P = 0.0487), suggesting that upregulation of vascular endothelial growth factor tends to increase vessel density in the white matter. We propose that downregulation of endothelin 1 and upregulation of vascular endothelial growth factor in the context of reduced ratio of myelin-associated glycoprotein to proteolipid protein 1 are likely to be protective physiological responses to reduced white matter perfusion. Further analysis of the Bristol cohort showed that endothelin 1 was reduced in the white matter in Alzheimer's disease (P
Original languageEnglish
Pages (from-to)1524-1532
Number of pages9
JournalBrain
Volume137
Issue number5
DOIs
Publication statusPublished - 10 May 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Groups and Themes

  • Cerebrovascular and Dementia Research Group

Keywords

  • Alzheimer's disease
  • brain ischaemia
  • cerebral blood flow
  • dementia
  • neuropathology
  • ENDOTHELIAL GROWTH-FACTOR
  • CEREBRAL AMYLOID ANGIOPATHY
  • CONVERTING ENZYME ACE
  • ACUTE ISCHEMIC STROKE
  • BETA-PEPTIDE
  • BLOOD-FLOW
  • RAT-BRAIN
  • ANGIOGENESIS
  • VEGF
  • PLASMA

Fingerprint

Dive into the research topics of 'Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia'. Together they form a unique fingerprint.

Cite this